Saroja Pharma Industries India Limited (NSE:SAROJA)

Market Cap	159.61M -18.3%
Revenue (ttm)	701.29M +30.5%
Net Income	16.18M +56.4%
EPS	4.02 +56.4%
Shares Out	4.02M
PE Ratio	9.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,200
Open	39.75
Previous Close	41.55
Day's Range	39.70 - 39.75
52-Week Range	28.00 - 51.75
Beta	0.58
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About NSE:SAROJA

Saroja Pharma Industries India Limited trades in, exports, and supplies pharma active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents in India, the Asia Pacific, Europe, and internationally. Its products are used in human, veterinary, and pharmaceutical products. Saroja Pharma Industries India Limited was incorporated in 2019 and is based in Mumbai, India.

• Industry: Industrial Distribution
• Sector: Industrials
• Founded: 2019
• Employees: 12
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAROJA

Financial Performance

In fiscal year 2026, NSE:SAROJA's revenue was 701.29 million, an increase of 30.53% compared to the previous year's 537.27 million. Earnings were 16.18 million, an increase of 56.45%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 28, 2026

Data Sources Report a data error